Keybanc Maintains Overweight on CryoPort, Raises Price Target to $20
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsPrice Target
Keybanc analyst Paul Knight maintains CryoPort (NASDAQ:CYRX) with a Overweight and raises the price target from $17 to $20.
Keybanc analyst Paul Knight maintains CryoPort (NASDAQ:CYRX) with a Overweight and raises the price target from $17 to $20.